The fate of a $6 billion bankruptcy settlement involving Purdue Pharma, the maker of the powerful and addictive pain medication OxyContin, hangs in the balance as the U.S. Supreme Court prepares to hear…
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.…
Teva Pharmaceutical Industries Ltd TEVA reported Q3 sales of $3.85 billion, beating the consensus of $3.72 billion. The 7% Y/Y increase was mainly due to higher revenues from generic products in all…
Stock futures indicate a subdued opening on Wednesday after several consecutive gains in major averages. Traders are eagerly awaiting Federal Reserve Chair Jerome Powell’s speech for insights into possible rate…